Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
about
Short-term administration of growth hormone (GH) lowers blood pressure by activating eNOS/nitric oxide (NO)-pathway in male hypophysectomized (Hx) rats.Early-onset growth hormone deficiency results in diastolic dysfunction in adult-life and is prevented by growth hormone supplementationVascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction.Growth hormone and the heart.The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.Young little mice express a premature cardiovascular aging phenotype.L-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging.Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf ratsHypopituitarism and atherosclerosis.Growth hormone deficiency and vascular risk.Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular agingCardiovascular effects of growth hormone treatment: potential risks and benefits.Growth hormone and IGF-1 deficiency exacerbate high-fat diet-induced endothelial impairment in obese Lewis dwarf rats: implications for vascular agingThe emerging role of IGF-1 deficiency in cardiovascular aging: recent advancesGrowth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study.Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.Pharmacological Strategies to Retard Cardiovascular AgingEndothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice.Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease.Reduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity.Protective actions of melatonin and growth hormone on the aged cardiovascular system.Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency.Recombinant GH replacement in hypopituitary adults improves endothelial cell function and reduces calculated absolute and relative coronary risk.Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults.Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome.Insulin-like growth factor-1 deficiency determines increased intima-media thickness at common carotid arteries in adult patients with growth hormone deficiency.Insulin sensitivity is impaired in adults with varying degrees of GH deficiency.Circulating ADMA concentrations are elevated in hypopituitary adults with and without growth hormone deficiency.Cardiac evaluation in children with Prader-Willi syndrome.Growth hormone (GH) treatment does not restore endothelial function in children with GH deficiency.Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy.Insulin resistance, metabolic syndrome and chronic low grade inflammation in Sheehan's syndrome on standard replacement therapy: a case control study.Characteristics of cardiac and vascular structure and function in Prader-Willi syndrome.Sympathetic nerve hyperactivity is associated with increased peripheral vascular resistance in hypopituitary patients with growth hormone deficiency.
P2860
Q24811861-753521F8-45C5-4E8F-B2AF-B0C6DE2BFA45Q30468957-0A74B8E9-E029-409C-973F-3F41050AB488Q30932991-795BB23E-480D-4C92-AE53-360EFD2E4049Q32026861-EF979E76-888B-4CA9-86C7-5D02671EB3B2Q33633368-D102F665-CC1B-43B2-A975-1A76E0F100E6Q33684553-24E628C7-7895-41BB-BAFA-50598DF0A992Q34070390-AE0BF80E-E74F-4D53-ADBB-E6F4027A4BF1Q34195272-0D20A954-DF6A-41A4-A99D-2FE67A560A7FQ34420018-B4CAA663-8C70-42E5-A65F-CE332D887D78Q34722657-44E2D2CC-BFE1-4C80-96AF-B267705D4F24Q35845272-F3E520F2-4796-41A3-B438-A75CF13D3D92Q35946594-E65CF37D-0915-4132-A027-53EBD4EE0AB0Q35947412-99D868DD-7430-4DDC-9AFC-13418040F796Q35947431-DAE13F11-8B23-406C-A8BC-6C42B4F2F926Q36732731-CF73A05F-BAF2-40D0-BB51-BAE13B6258CCQ36755284-3235BB38-D25C-44D3-97EC-EE5483A62099Q36972415-69A39E7D-AE60-4A55-A383-B1129F22C93AQ37038972-314C9887-7640-4FBB-AB36-846020FE91D1Q37145687-281FCA3B-E1EF-441C-AD8B-507F306BA53BQ37482792-F38643D0-FED5-437F-BCC3-C2E5842EB929Q38267485-D516D505-B702-4CA4-94E9-9D447A05B28FQ42520402-01AD37EA-0259-4247-B65C-DE486AA7FFDBQ42635318-146FA212-A833-43A4-9D83-7D1E3D9C5873Q43917955-300BEC2F-0F5B-4173-AD80-78971F9BF82CQ43967285-A791A59D-4E12-415C-8FA2-EA7E19E11D93Q43967295-7C635B1B-36FD-4F32-A456-2CA9664A1D20Q45050050-C1F816FE-6818-4A8E-82B9-2AB357A942CDQ45237930-18C46E4F-D721-49D6-A1CC-DEC82F093A68Q45283840-E41C7DCC-97D4-480B-A92C-BA8782439D16Q46325572-F3BEB085-0F7E-454D-8B98-02E8CD1CF9B1Q46537680-2B0E98C3-09F2-4CB4-8657-BE44302E8307Q46789858-84C3DC46-B690-4967-B2EC-6B0063557D63Q48495807-2C83E9B7-D04D-49F8-93AE-3AE2FEE51F4BQ51321723-C8C4B255-5480-4A0A-8604-A85E621C6175Q51473092-241433B4-C6DD-415C-A005-06E93E269D2CQ52861514-2863EF42-F860-465B-A5CE-1384C3EF69A5
P2860
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
@en
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
@nl
type
label
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
@en
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
@nl
prefLabel
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
@en
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
@nl
P2093
P2860
P1476
Endothelial dysfunction in hypopituitary adults with growth hormone deficiency.
@en
P2093
P2860
P304
P356
10.1046/J.1365-2265.1999.00671.X
P577
1999-04-01T00:00:00Z